{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:38Z","timestamp":1793079158158,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yebeh.2026.111248","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:28:10Z","timestamp":1788622090000},"page":"111248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS\u00ae System"],"prefix":"10.1016","volume":"185","author":[{"given":"Arnold R.","family":"Gammaitoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha J.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1068-1797","authenticated-orcid":false,"given":"Daniel","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Tcheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairn G.","family":"Seale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miganush","family":"Stepanians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-3327","authenticated-orcid":false,"given":"Bradley S.","family":"Galer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Motley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2026.111248_b0005","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/epi.17568","article-title":"Reasons for ineligibility for clinical trials of patients with medication-resistant epilepsy","volume":"64","author":"Kerr","year":"2023","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111248_b0010","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/epi.13212","article-title":"A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures","volume":"56","author":"Klein","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111248_b0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(19)30399-0","article-title":"Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial","volume":"19","author":"Krauss","year":"2020","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2026.111248_b0020","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/epi.18444","article-title":"The human photosensitive epilepsy model for clinical proof-of-principle trials of novel antiseizure medications: 2. Analysis of drug trials and predictive value of the model","volume":"66","author":"L\u00f6scher","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111248_b0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2016.11.016","article-title":"The photosensitivity model is not a model for partial (focal) seizures","volume":"133","author":"Porter","year":"2017","journal-title":"Epilepsy Res"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111248_b0030","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/epi.17621","article-title":"Time-to-event clinical trial designs: existing evidence and remaining concerns","volume":"64","author":"Kerr","year":"2023","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111248_b0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1474-4422(18)30038-3","article-title":"Diagnostic challenges in epilepsy: seizure under-reporting and seizure detection","volume":"17","author":"Elger","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2026.111248_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108383","article-title":"Seizure documentation in people living with epilepsy","volume":"125","author":"Goldstein","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111248_b0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022772","article-title":"Mechanisms responsible for cognitive impairment in epileps","volume":"5","author":"Lenck-Santini","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111248_b0050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40120-022-00342-y","article-title":"Clinical characteristics and prognostic significance of subclinical seizures in focal epilepsy: a retrospective study","volume":"11","author":"He","year":"2022","journal-title":"Neurol Ther"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2026.111248_b0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.eplepsyres.2013.04.008","article-title":"Designing a new proof-of-principle trial for treatment of partial seizures to demonstrate efficacy with minimal sample size and duration-a case study","volume":"106","author":"French","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111248_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106302","article-title":"Electrocorticographic events from long-term ambulatory brain recordings can potentially supplement seizure diaries","volume":"161","author":"Quigg","year":"2020","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111248_b0065","first-page":"9","article-title":"Biomarkers: an emerging tool for diagnosis of a disease and drug development","volume":"1","author":"Sahu","year":"2011","journal-title":"Asian J Res Pharm Sci"},{"key":"10.1016\/j.yebeh.2026.111248_b0070","series-title":"Biomarkers for drug discovery and development. The Handbook of Biomarkers","first-page":"113","author":"Jain","year":"2017"},{"issue":"8","key":"10.1016\/j.yebeh.2026.111248_b0075","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000001280","article-title":"Long-term treatment with responsive brain stimulation in adults with refractory partial seizures","volume":"84","author":"Bergey","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111248_b0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/epi.12998","article-title":"Interrater reliability in interpretation of electrocorticographic seizure detections of the responsive neurostimulator","volume":"56","author":"Quigg","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111248_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/epi.16412","article-title":"Early detection rate changes from a brain-responsive neurostimulation system predict efficacy of newly added antiseizure drugs","volume":"61","author":"Quraishi","year":"2020","journal-title":"Epilepsia"},{"issue":"13","key":"10.1016\/j.yebeh.2026.111248_b0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1212\/WNL.0b013e3182302056","article-title":"Responsive cortical stimulation for the treatment of medically intractable partial epilepsy","volume":"77","author":"Morrell","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111248_b0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/epi.12534","article-title":"Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System pivotal trial","volume":"55","author":"Heck","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111248_b0100","doi-asserted-by":"crossref","unstructured":"Motley WM, Quraishi IH, Nolan N, Friedman D, Landazuri P, Rao V, et al. Efficacy and tolerability of RAP-219, a potential first-in-class negative allosteric modulator of \u03b38 transmembrane AMPA receptor associated protein: impact on RNS long episodes and focal seizures [abstract]. Presented at American Epilepsy Society Annual Meeting, December 5-9, 2025, Atlanta, GA.","DOI":"10.1212\/WNL.0000000000216447"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111248_b0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpainsymman.2005.08.018","article-title":"Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable","volume":"31","author":"Farrar","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111248_b0110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.acra.2012.09.006","article-title":"Applications of ROC analysis in medical research: recent developments and future directions","volume":"19","author":"Alemayehu","year":"2012","journal-title":"Acad Radiol"},{"key":"10.1016\/j.yebeh.2026.111248_b0115","unstructured":"Spencer D, Quigg M, Fountain N, Jarosiewicz B, Skarpaas T, Morrell M. Electrographic events recorded by a responsive neurostimulator may provide an objective assessment of clinical seizure burden [abstract]. Presented at American Epilepsy Society Annual Meeting, November 30\u2013December 4, 2018, New Orleans, LA."},{"key":"10.1016\/j.yebeh.2026.111248_b0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yebeh.2018.04.003","article-title":"Clinical and electrocorticographic response to antiepileptic drugs in patients treated with responsive stimulation","volume":"83","author":"Skarpaas","year":"2018","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:41:06Z","timestamp":1793076066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S1525505026003690"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111248","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS\u00ae System","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111248"}}